- Home
- HOOK vs CLRO Comparison
HOOK vs CLRO Comparison
Compare HOOK & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- CLRO
- Stock Information
- Founded
- HOOK 2011
- CLRO 1983
- Country
- HOOK United States
- CLRO United States
- Employees
- HOOK N/A
- CLRO N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- CLRO Radio And Television Broadcasting And Communications Equipment
- Sector
- HOOK Health Care
- CLRO Technology
- Exchange
- HOOK Nasdaq
- CLRO Nasdaq
- Market Cap
- HOOK 9.3M
- CLRO 12.5M
- IPO Year
- HOOK 2019
- CLRO N/A
- Fundamental
- Price
- HOOK $1.47
- CLRO $0.52
- Analyst Decision
- HOOK Buy
- CLRO
- Analyst Count
- HOOK 4
- CLRO 0
- Target Price
- HOOK $10.67
- CLRO N/A
- AVG Volume (30 Days)
- HOOK 134.3K
- CLRO 25.2K
- Earning Date
- HOOK 05-20-2025
- CLRO 05-19-2025
- Dividend Yield
- HOOK N/A
- CLRO 94.34%
- EPS Growth
- HOOK N/A
- CLRO N/A
- EPS
- HOOK N/A
- CLRO N/A
- Revenue
- HOOK $43,946,000.00
- CLRO $11,386,000.00
- Revenue This Year
- HOOK N/A
- CLRO N/A
- Revenue Next Year
- HOOK N/A
- CLRO N/A
- P/E Ratio
- HOOK N/A
- CLRO N/A
- Revenue Growth
- HOOK 118.32
- CLRO N/A
- 52 Week Low
- HOOK $0.72
- CLRO $0.43
- 52 Week High
- HOOK $10.50
- CLRO $1.40
- Technical
- Relative Strength Index (RSI)
- HOOK 67.61
- CLRO 46.00
- Support Level
- HOOK $1.14
- CLRO $0.50
- Resistance Level
- HOOK $1.67
- CLRO $0.59
- Average True Range (ATR)
- HOOK 0.16
- CLRO 0.04
- MACD
- HOOK 0.10
- CLRO 0.01
- Stochastic Oscillator
- HOOK 78.69
- CLRO 37.27
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.